ROKITAN GmbH | Rokitan
Rokitan, based in Vienna, is a pharmaceutical manufacturer of etablished products.
pharma, anti-infective products, vitamins, Rokivit, Rokiprim, Lidaprim
5
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-5,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,qode-content-sidebar-responsive,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.4.1,vc_responsive

Established niche pharmaceutical products

Story

We are an independent, fully-privately owned pharmaceutical company.

Our offices are in Vienna.

We acquire, develop and supply established medical products in Europe.

Acquire. Manufacture. Market.

We acquire established branded healthcare products from multinational and speciality pharmaceutical companies

Develop. Manufacture. Market.

With new formulations and new markets, we develop healthcare products in well-defined therapeutic areas

Partner

We build partnerships to expand our portfolio. We offer a nimble approach to partnering and collaboration. We have good knowledge of central European healthcare markets and access to key medical opinion leaders.

Quality

We follow and implement high standards of quality and excellence

Products

Finished Dosage Forms

Anti Infectives and Vitamins

Rokiprim Rokiprim For the treatment of gram +/- infectious diseases Rokiprim solution for infusion contains a combination of Sulfametrol and Trimethoprim. The two chemotherapeutic agents are effective against a broad range of both gram negative and gram positive microorganisms. The indications are for the treatment of infections of the urinary, gastrointestinal, respiratory and genital tract and of the skin. Product Information   Lidaprim Lidaprim Well-proven oral anti-biotic Lidaprim film coated tablets, containing Sulfametrol and Trimethoprim, allow for the oral treatment of the same range of infections as Rokiprim. For more severe infections, Rokiprim should be administered. Product Information   Rokivit Rokivit D3 Dietary supplement for the treatment of Vitamin D3 deficiency Product Information

Active Pharmaceutical Ingredients (APIs)

Sulfametrole

Sulfametrole combined with trimethoprim shows bactericidal and fungicidal activity (Pneumocystis jirovecii). The spectrum of activity of the combination covers gram-positive and gram-negative microorganisms.

Partner with us

For vendors

We understand well the requirements of vendors to conduct transactions efficiently

Offer process

We have experience and detailed knowledge of international M & A transactions. We understand what matters and we execute quickly

During transfer

We have good actual experience of asset transfers and will ensure efficient transition

After transfer

We invest in the brands and ensure that they remain available to patients as a proven therapy option

For partners

We have country-specific expertise in Europe. We offer a range of services, including supply and commercialisation and market access.

We are interested in products for well-defined niche markets and for therapeutic areas we are currently active in.

Partnering opportunities

We are looking for knowledgeable partners to market and commercialise our products in the Americas, Asia-Pacific and Africa.

Interested to dispose products or licence out?

Team

Simon Adler

Simon has over 12 years of experience in pharmaceutical and healthcare management. Before that, he worked for 10 years in Investment Banking at Lehman Brothers and UBS Investment Bank (formerly S.G. Warburg) in London where he advised in senior roles on a variety of M & A and equity transactions. His sector focus included healthcare and biotechnology and the geographical focus Central and Southern Europe.

Whilst working for Medichron Simon met Gerfried Nell and decided to set up a speciality pharma business together. Simon completed his doctoral studies at the University of Cambridge (Fitzwilliam College) and obtained a Masters degree in Economics from the College of Europe in Bruges. Simon is member of the Executive Board of the Leo Baeck Institute London.

Gerfried Nell

Gerfried has over 30 years of experience in international pharma. Before founding Rokitan with Simon, he set up NPC Connect assisting pharmaceutical companies in medical, regulatory and market access affairs. He also acted as a senior clinical investigator. Before, Gerfried worked at Ciba-Geigy and Novartis Austria as Medical Director in charge of clinical research, registration, reimbursement, pharmacovigilance, quality assurance and medical affairs. Previously, he was with Eli Lilly (Indianapolis, USA) and Altana (Konstanz, Germany) as senior medical researcher in Clinical Pharmacology.

Gerfried was educated at the Medical University of Vienna where he received his PhD in medicine. Subsequently, he was awarded a Professorship at Saarland University and worked as senior lecturer in pharmacology. Gerfried is a senior member of IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine).

Contact

Please get in touch with us

+43 1 216 32 75

Grosse Mohrengasse 10, 1020 Wien

office@rokitan.com

If you want to report an adverse event or product complaint please use the contact details above.

Wenn Sie eine Nebenwirkung oder einen Qualitätsmangel melden möchten, nutzen Sie bitte auch die oben genannten Kontaktdaten.

Datenschutzerklärung (Data privacy statement as required by EU law)

VAT No. (UID): ATU 63291217

Company Registration Number: FN 290019 z

    * mandatory fields